Hidden immune defence may unlock better responses in small cell lung cancer
Researchers at the Walter and Eliza Hall Institute have discovered that gamma delta T cells can help the immune system identify and attack small cell lung cancer. This finding could lead to more effective immunotherapies for a disease that has historically been difficult to treat.
Why it matters
This discovery offers a potential breakthrough in treating one of the deadliest forms of cancer by bypassing the tumor's ability to hide from the immune system.
An aggressive cancer that has spent decades perfecting the art of hiding from the immune system may finally have met its match.
Researchers at the Walter and Eliza Hall Institute have identified a previously overlooked type of immune cell that can recognise and kill small cell lung cancer (SCLC), the deadliest form of the disease, which claims most of its patients within five years of diagnosis.
Published in Cancer Cell, the study found patients whose tumours carried more of these specialised cells lived longer and responded better to treatment, revealing a hidden immune defence that could be harnessed against a cancer that has seen little therapeutic progress in decades.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in